RPT904

· RAPT Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPT904, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy [Phase 2]